~3 min read · 796 words
Quarterly historical financials trend — LWLG
Multi-quarter trendline of revenue, gross margin proxy, operating expenses, and cash burn. Drawn from 10-Q filings via SEC EDGAR + community summaries (IH x993231 stickies cross-checked).
Quarterly trajectory
8 quarters · revenue / net-loss / cashRevenue
Net loss (downward)
Cash on hand
Source: 10-K / 10-Q via SEC EDGAR Faded bars = estimated (not directly disclosed)
Quarterly P&L summary
| Quarter | Revenue | Net loss | EPS | Shares O/S | Cash | Notable |
|---|---|---|---|---|---|---|
| Q1 2024 | (low six figures) | (~$5.5M) | (~$0.05) | ~120M | ~$45M | Pre-LeMaitre |
| Q2 2024 | (low six figures) | (~$5.0M) | (~$0.04) | ~120M | ~$40M | LeMaitre to Board (Jul) |
| Q3 2024 | (low six figures) | (~$5.5M) | (~$0.05) | ~122M | ~$35M | ”Partnership timeline shifts” |
| Q4 2024 | (low six figures) | (~$6.5M) | (~$0.05) | ~125M | ~$30M | Lebby retires Dec 11; LeMaitre CEO |
| FY2024 total | $96K | $22.5M | $0.19 | 124,799,620 (filing) | ~$30M | |
| Q1 2025 | $23K | (~$5.0M) | (~$0.04) | ~127M | ~$25M | First quarter under LeMaitre |
| Q2 2025 | (restated; ~$50K) | (~$4.5M) | (~$0.04) | ~130M | ~$22M | Telcordia 1000h pass Jul 15 |
| Q3 2025 | $29K Q / $77K YTD | $5.10M | $0.04 | 132,705,151 | ~$35M | First Stage-3 announcement Nov 4 |
| Q4 2025 | (~$160K, balancing FY) | (~$5.7M) | (~$0.04) | 148,831,122 (filing) | $69M | Titan offering $35M Dec 15 |
| FY2025 total | $237K (+147%) | $20.3M | $0.16 | 148.8M | $69M | |
| Q1 2026 (est.) | TBD May 8 ~filing | TBD | TBD | 150,610,710 (proxy record) | TBD | Apr ATM amend $51.4M shelf |
Trends
Revenue trajectory
- FY2024 → FY2025: $96K → $237K (+147%) — ramp begins from microscopic base
- Historical pre-2024: roughly flat ~$50-100K/yr — research grants + sample shipments
- Inflection signal: Q3 2025 had higher quarterly revenue than entire FY2024 — early sign of customer engineering programs paying NRE/license fees
Operating expense
- Quarterly OpEx ~$5.5-6.5M throughout 2024-2025 — consistent burn
- 34 FTEs at YE 2025 (23 R&D / 11 SG&A) — modest increase from 2024
- R&D is ~70% of headcount → ~70% of OpEx is technical investment
- LeMaitre stated “engineering capacity is the bottleneck” (per ECOC Sep 2025) — expect 2026 OpEx growth as headcount expands to onboard new customers
Net loss trajectory
- FY2024: $22.5M / FY2025: $20.3M (-10% improvement)
- Improvement driven by modest revenue growth + flat OpEx
- 2026 likely sees wider net loss as headcount expansion outpaces revenue growth (typical pre-commercial pattern)
Cash burn cadence
- Quarterly cash burn ~$5-6M from operations
- Plus capital deployment: ATM tranches + occasional offerings
- Net cash position trajectory:
- YE 2024: ~$30M
- Mid 2025: ~$22M
- YE 2025: $69M (post Titan offering + ATM)
- Apr 2026: TBD (ATM amended to $51.4M shelf)
- “Funded beyond Dec 2027” per Q4 2025 call — assumes continued ATM use ~$15-25M
Share count trajectory (dilution)
- Q1 2024: ~120M
- Q4 2025: 148.8M
- DEF 14A 2026 record date Apr 6: 150,610,710
- ~25% increase in 2 years — significant dilution
- Plus 8.2M options/warrants outstanding YE 2025 → ~158.8M fully-diluted
Gross-margin progression
LWLG does not publicly disclose product-level gross margin (revenue is too small). The Jan 2026 deck targets 60%+ GM at scale:
- Material sales: ~50% GM (industry standard for specialty chemicals)
- IP/PDK licensing: ~95%+ GM (pure margin business)
- Blended target 60%+ implies materials-heavy revenue mix initially, with IP/license growing share over time
Burn-to-revenue scaling chart (conceptual)
FY2023 FY2024 FY2025 FY2026E FY2027E FY2028E
Revenue: ~$50K $96K $237K ~$1M ~$10M ~$50M+
Net loss: ($21M) ($22M) ($20M) ($25M) ($25M) ($10M)
Cash: $50M+ $30M $69M ~$50M ~$30M ~$50M+
Stage 3: 0 0 1 3-4 4-5 Stage-4 conversion
(Note: Estimates 2026-2028 are scenarios, not forecasts.)
Key trend observations
- Revenue trajectory is the gating metric — until Stage-3 → Stage-4 conversion drives material licensing fees, revenue stays in low-$M
- Burn discipline maintained — LWLG hasn’t dramatically expanded OpEx pre-revenue (unlike many speculative photonics companies)
- Capital cadence is predictable — every 6-9 months, additional capital is raised via ATM or offering; investors should expect this rhythm
- Gross-margin disclosure post-Stage-4 will be the single most important new financial metric
Open questions
- What was Q1 2026 revenue (10-Q ~May 8 2026)?
- Will FY2026 revenue exceed $1M? (Need 4× FY2025 to suggest customer-engineering program acceleration)
- When does first commercial PO disclosure appear in a 10-Q?
- Will LWLG break out revenue by segment (materials vs licensing vs NRE) once volume grows?
Sources
- LWLG 10-K filings (FY2024, FY2025) via SEC EDGAR
- LWLG 10-Q filings (Q1 2024 through Q3 2025) via SEC EDGAR
- DEF 14A 2026 (filed Apr 10, 2026) — share count
- IH x993231 sticky #177,317,896 (“13-F, Quarterly Changes, Short Interest Price and Changes”)
- See
kb/_agent_outputs/sec_capital_insiders.mdfor filings detail - See
kb/05_financials/financials_summary.mdfor current snapshot